New combo therapy targets liver tumors directly
NCT ID NCT06311851
First seen Jan 07, 2026 · Last updated May 13, 2026 · Updated 21 times
Summary
This study tests a new way to treat liver metastases by combining a drug called bevacizumab with a procedure called TACE, which delivers chemotherapy directly to the liver. The goal is to see if this combination helps patients live longer and shrinks tumors better than TACE alone. About 40 adults with liver metastases that cannot be surgically removed will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pardis Noor Medical Imaging and Cancer Center
RECRUITINGTehran, Tehran Province, 021, Iran
Contact
Conditions
Explore the condition pages connected to this study.